b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31203574</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>26</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1699-3055</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>22</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Apr</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Clinical &amp; translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</Title>\n                <ISOAbbreviation>Clin Transl Oncol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22/AKT signaling.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>563-575</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12094-019-02160-5</ELocationID>\n            <Abstract>\n                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Type 3 innate lymphocytes (ILC3s) are reported to be involved in lung cancer, possibly by producing interleukin-22 (IL-22). However, whether ILC3s and their secreted IL-22 molecules contribute to the pathogenesis of pancreatic cancer (PC) remains unclear. To this end, in this study, we investigated the effects and possible mechanisms of ILC3s on PC pathogenesis.</AbstractText>\n                <AbstractText Label="METHOD" NlmCategory="METHODS">The IL-22 and IL-2i2R levels and the ILC3s\' frequency in cancer tissues from PC patients and in peripheral blood from PC patients and healthy controls were analyzed by flow cytometry, immunochemistry, or immunofluorescence. The effects of IL-22-induced AKT signaling on the proliferation, invasion, and migration of PC cells were examined by co-culturing PC cell lines with ILC3s isolated from PC tissues, with or without the addition of neutralizing IL-22 antibody, IL-22R antibody or AKT inhibitor.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Our results showed that IL-22 and ILC3s were significantly upregulated in the PBMCs and cancer tissues of PC patients, and the IL-22R level was increased in PC cells. The increased frequency of ILC3s was positively correlated with the clinical features of PC patients. Co-culture experiments indicated that ILC3s promoted the proliferation, invasion, and migration of PC cell lines by secreting IL-22 to activate AKT signaling because IL-22/IL-22R or AKT blockage markedly counteracted such effects on PC cells.</AbstractText>\n                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our data demonstrated that ILC3s may promote PC pathogenesis through IL-22/IL-22R-AKT signaling, suggesting a potential intervention target for PC treatment in the future.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Xuan</LastName>\n                    <ForeName>X</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathophysiology, College of High Altitude Military Medicine, Third Military Medical University, Chongqing, 400038, China.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Kidney, Southwest Hospital, Army Medical University (Third Military Medical University), 30 Gaotanyan Street, District Shapingba, Chongqing, 400038, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhou</LastName>\n                    <ForeName>J</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Immunology, PLA, Third Military Medical University, Chongqing, 400038, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tian</LastName>\n                    <ForeName>Z</ForeName>\n                    <Initials>Z</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Immunology, PLA, Third Military Medical University, Chongqing, 400038, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lin</LastName>\n                    <ForeName>Y</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Bellevue Christian High School, 1601 98th Ave NE, Bellevue, WA, 98004, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Song</LastName>\n                    <ForeName>J</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Microbial Pathogenesis and Immunology, Texas A&amp;M University Health Science Center, College Station, TX, 77843, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ruan</LastName>\n                    <ForeName>Z</ForeName>\n                    <Initials>Z</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ni</LastName>\n                    <ForeName>B</ForeName>\n                    <Initials>B</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9787-1416</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathophysiology, College of High Altitude Military Medicine, Third Military Medical University, Chongqing, 400038, China. 15991833423@163.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhao</LastName>\n                    <ForeName>H</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Kidney, Southwest Hospital, Army Medical University (Third Military Medical University), 30 Gaotanyan Street, District Shapingba, Chongqing, 400038, China. zhaohw212@126.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yang</LastName>\n                    <ForeName>W</ForeName>\n                    <Initials>W</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, The 181th Hospital of PLA, No. 1 Xinqiaoyuan Road, Guilin, 541002, Guangxi Zhuang Autonomous Region, China. 1512638974@qq.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>No. 2016YFA0502203</GrantID>\n                    <Agency>This work was supported by grants from the National Key Research and Development Plan of China</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>No. 81670534</GrantID>\n                    <Agency>the National Science Foundation of China</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>81471531</GrantID>\n                    <Agency>the National Science Foundation of China</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>No. 2015GXNSFAA139170</GrantID>\n                    <Agency>Guangxi Natural Science Foundation Project</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>No. SWH2016LHYS-04</GrantID>\n                    <Agency>Medical Scientific and Technological Innovation Funds of Southwest Hospital</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>15</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Italy</Country>\n            <MedlineTA>Clin Transl Oncol</MedlineTA>\n            <NlmUniqueID>101247119</NlmUniqueID>\n            <ISSNLinking>1699-048X</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">AKT signaling</Keyword>\n            <Keyword MajorTopicYN="N">IL-22</Keyword>\n            <Keyword MajorTopicYN="N">IL-22R</Keyword>\n            <Keyword MajorTopicYN="N">ILC3</Keyword>\n            <Keyword MajorTopicYN="N">Pancreatic cancer</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>24</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>08</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31203574</ArticleId>\n            <ArticleId IdType="doi">10.1007/s12094-019-02160-5</ArticleId>\n            <ArticleId IdType="pii">10.1007/s12094-019-02160-5</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Infect Dis. 2014 Aug 1;210(3):493-503</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24577508</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2010 Apr 29;464(7293):1367-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20200518</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2015 Jun 1;136(11):2556-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25370454</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pancreatology. 2018 Apr;18(3):231-237</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29502986</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Immunol. 2011 Nov;12(11):1045-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21946417</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2019 Jul;121(1):5-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31110329</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2011;6(7):e21799</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21789181</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Exp Med. 2013 May 6;210(5):917-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23589566</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Immunol Rev. 2012 Jan;245(1):177-88</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22168420</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Sci (Lond). 2016 Feb;130(4):247-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26590104</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Exp Immunol. 2012 May;168(2):192-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22471280</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Dermatol Sci. 2010 Jun;58(3):225-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20418068</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2007 May;117(5):1175-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17476347</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Immunol. 2013 Feb;13(2):145-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23348417</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2017 Aug 1;127(8):2916-2929</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28650339</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Immunol. 2015 Aug;45(8):2171-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26031799</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Med Rep. 2014 Sep;10(3):1335-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25017645</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Annu Rev Immunol. 2012;30:647-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22224763</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Immunol. 2013 Sep;14(9):937-48</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23913046</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2014 Sep 12;345(6202):1254009</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25214634</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Immunity. 2004 Aug;21(2):241-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15308104</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Immunity. 2012 Feb 24;36(2):276-87</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22306017</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2015 Sep 23;6:8280</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26395069</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Dig Dis. 2011;29(2):235-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21734390</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Immunol Immunother. 2012 Nov;61(11):1965-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22527243</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Immunol. 2011 Aug;31(4):606-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21556937</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Immunol. 2008 May;9(5):503-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18425107</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2015 Jan 15;517(7534):293-301</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25592534</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Immunol. 2010 Jul 15;185(2):1177-85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20566828</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Immunol. 2011 May;12(5):383-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21502992</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Treat Res. 2006;130:1-38</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16610701</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tumour Biol. 2016 Jan;37(1):105-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26541758</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Metastasis Rev. 2011 Mar;30(1):13-25</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21271351</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'